最新报道:Litecoin (LTC) surged over 10% after biopharmaceutical firm MEI Pharma disclosed an unexpected $100 million investment in cryptocurrency, primarily allocated to Litecoin. The Nasdaq-listed company revealed in an SEC filing that it holds 581.5 LTC, valued at roughly $53,000, alongside Bitcoin and Ethereum. MEI Pharma's CFO stated the move aims to diversify treasury assets, though the firm clarified it won't engage in crypto trading. The announcement sparked speculation about institutional adoption, with Litecoin founder Charlie Lee tweeting approval of the "smart corporate treasury move." The investment represents nearly half of MEI Pharma's $208 million market cap, raising eyebrows given its clinical-stage biotech focus.